Skip to content

Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty

Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03973320
Enrollment
11292
Registered
2019-06-04
Start date
2018-12-27
Completion date
2019-11-18
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Database, Hypotension, Primary Total Hip Arthroplasty, Total Hip Arthroplasty

Brief summary

This is a retrospective chart review to determine if neuraxial anesthesia is associated with worse outcomes after Primary Total Hip Arthroplasty.

Detailed description

The goal of this study is to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty. The plan to analyze the outcomes is listed below: Primary outcomes: Multiple logistic regression will be used to compute the adjusted odds ratios of any postoperative complications (MI, CVA, death) , adjusting for covariates including duration of intraoperative mean arterial pressure of less than pre-defined threshold, such as 55, or 60 mmHg mean blood pressure. Sensitivity analyses will also consider the effects of intra-operative hypotension (IOH) defined as mean blood pressure of less than 40, 45, 50, 55, 60, and 65 mm Hg. Secondary outcomes: Multiple logistic regression will be to compute the adjusted odds ratios of individual postoperative complications, (such as MI, CVA, stroke) , adjusting for covariates including duration of intraoperative mean blood pressure of less than pre-defined threshold, such as 55, or 60 mmHg mean blood pressure. Sensitivity analyses will also be conducted to test the effects of extend of IOH on complications.

Interventions

OTHERChart Review

This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty patients.

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All primary total hip arthroplasty patient data with sufficiently complete intraoperative vital signs

Exclusion criteria

* Revision primary total hip arthroplasty * Incomplete intraoperative vital signs * Anterior total hip arthroplasty

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or MortalityDay of Surgery (Day 0) through discharge (days til discharge is an average of 2 days), follow-ups up to 30 days post-surgeryThe association between levels and length of intraoperative controlled hypotension and incidence rates of individual and composite outcome of any of the following events: (i) myocardial infarction (MI), (ii) cerebrovascular accident (CVA), (iii) death. If any of these events are positive, then the composite outcome will be positive. The units of measurement will be the same.

Countries

United States

Participant flow

Participants by arm

ArmCount
Primary Total Hip Arthroplasty Without Complications
This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty Chart Review: This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty patients.
11,224
Primary Total Hip Arthroplasty With Common Complications
This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty Chart Review: This is a chart review to determine if hypotensive neuraxial anesthesia is associated with worse outcomes in Primary Total Hip Arthroplasty patients.
68
Total11,292

Baseline characteristics

CharacteristicPrimary Total Hip Arthroplasty With Common ComplicationsTotalPrimary Total Hip Arthroplasty Without Complications
Age, Continuous75.6 years64 years64 years
Anesthetic type: Epidural/CSE52 Participants7692 Participants7640 Participants
Anesthetic type: Spinal16 Participants3600 Participants3584 Participants
ASA of 1 & 237 Participants9291 Participants9254 Participants
ASA of 331 Participants2001 Participants1970 Participants
BMI (Body Mass Index)28 kg/m^228.1 kg/m^228.1 kg/m^2
Race/Ethnicity, Customized
Race: White
49 Participants9891 Participants9842 Participants
Sex: Female, Male
Female
30 Participants5985 Participants5955 Participants
Sex: Female, Male
Male
38 Participants5307 Participants5269 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
3 / 11,292
other
Total, other adverse events
18 / 11,292
serious
Total, serious adverse events
0 / 11,292

Outcome results

Primary

Number of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or Mortality

The association between levels and length of intraoperative controlled hypotension and incidence rates of individual and composite outcome of any of the following events: (i) myocardial infarction (MI), (ii) cerebrovascular accident (CVA), (iii) death. If any of these events are positive, then the composite outcome will be positive. The units of measurement will be the same.

Time frame: Day of Surgery (Day 0) through discharge (days til discharge is an average of 2 days), follow-ups up to 30 days post-surgery

Population: 21 patients out of 11,292 fit complication definition.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Primary Total Hip ArthroplastyNumber of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or MortalityMyocardial Infarction16 Participants
Primary Total Hip ArthroplastyNumber of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or MortalityStroke2 Participants
Primary Total Hip ArthroplastyNumber of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or MortalityIn-Hospital mortality0 Participants
Primary Total Hip ArthroplastyNumber of Participants Who Experience Myocardial Infarction, Cerebrovascular Accident, or Mortality30-day mortality3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026